GHSFs designated as sites of death (n = 698)

GHSFs not designated (n = 156)

p-value

Reduced oral intake (number, %)

646

(92.6)

135

(86.5)

0.02

Sleepiness during daytime (number, %)

512

(73.4)

101

(64.7)

0.03

Less vigor (number, %)

350

(50.1)

74

(47.4)

0.54

Oliguria (number, %)

486

(69.6)

117

(75.0)

0.18

Dyspnea (number, %)

341

(48.9)

100

(64.1)

<0.01

Edema (number, %)

278

(39.8)

72

(46.2)

0.15

Complaints of pain (number, %)

41

(5.9)

20

(12.8)

<0.01